3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Biphenotypic, Acute
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Leukemia, Myeloid, Accelerated Phase
4
Blast Crisis
4
Down Syndrome
3
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Urinary Bladder Neoplasms
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Primary Myelofibrosis
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Mouth Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Pemetrexed
8
Spinal Puncture
5
Specimen Handling
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
aflutinib
3
Trastuzumab
3
Bevacizumab
3
trastuzumab deruxtecan
2
pembrolizumab
2
osimertinib
2
Radiotherapy, Intensity-Modulated
2
tucatinib
1
toripalimab
1
sintilimab
1
sacituzumab govitecan
1
pertuzumab
1
peginterferon alfa-2b
1
lorlatinib
1
lenvatinib
1
azeliragon
1
avelumab
1
adavosertib
1
Temozolomide
1
Referral and Consultation
1
Radiosurgery
1
Radiation
1
Probability
1
Physical Examination
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
merphos
×
1 year
×
Clear all
No trials found.